NASDAQ:BIMI BIMI (BIMI) Stock Price, News & Analysis → Better than Bitcoin? The Biotech Stock with 46,751% Potential (From Behind the Markets) (Ad) Free BIMI Stock Alerts $1.23 +0.04 (+3.36%) (As of 04/26/2024 ET) Add Compare Share Share Today's Range$1.16▼$1.3050-Day Range$1.05▼$4.0052-Week Range$0.71▼$4.13Volume40,887 shsAverage Volume69,115 shsMarket Capitalization$14.26 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial Media Get BIMI alerts: Email Address Ad Weiss RatingsProtect Yourself While There’s Still Time …The next step of the Fed's control is here. Section 702 of the Foreign Intelligence Surveillance Act was renewed for two more years and passed into law earlier this week. Allowing the Fed to tighten its grip on your personal privacy and freedom.4 simple steps to protect your privacy and money before it’s too late. About BIMI Stock (NASDAQ:BIMI)BIMI Holdings Inc., together with its subsidiaries, engages in the retail and wholesale distribution of medical devices, and pharmaceutical and other healthcare products in the People's Republic of China. The company operates in four segments: Wholesale Pharmaceuticals, Wholesale Medical Devices, Medical Services, and Retail Pharmacies. It distributes Stryker spinal products, Olympus endoscopes, imported imaging products, and diagnostic imaging equipment to drug stores, private clinics, pharmaceutical dealers, and hospitals in the Southwest region of the People's Republic of China. The company also distributes varieties of products, including raw ingredients for pharmaceutical products, antibiotics, cardiovascular drugs, and anti-obesity medicines. In addition, it offers prescription and over-the-counter drugs, nutritional supplements, traditional Chinese medicines, personal and family care products, medical devices, and miscellaneous items under the Lijiantang Pharmacy brand name. Further, the company provides medical services in the hospitals, as well as IT research and development services; and operates two private hospitals in China. It sells its medicine and other healthcare products to customers through its directly owned stores. The company was formerly known as BIMI International Medical Inc. and changed its name to BIMI Holdings Inc. in January 2024. BIMI Holdings Inc. was incorporated in 2000 and is headquartered in New York, New York.Read More BIMI Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart BIMI Stock News HeadlinesApril 23, 2024 | globenewswire.comBIMI Announces Receipt of a Delinquency Compliance Alert Notice from NasdaqApril 17, 2024 | americanbankingnews.comBIMI Holdings Inc. (NASDAQ:BIMI) Short Interest UpdateApril 27, 2024 | Behind the Markets (Ad)Better than Bitcoin? The Biotech Stock with 46,751% Potential4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.April 15, 2024 | finance.yahoo.comBIMI Holdings Inc. (BIMI)April 9, 2024 | finanznachrichten.deValimail Triumphs at the 20th Annual 2024 Globee Awards for CybersecurityApril 9, 2024 | finance.yahoo.comValimail Triumphs at the 20th Annual 2024 Globee(R) Awards for CybersecurityApril 3, 2024 | finance.yahoo.comValimail DMARC Solution Available in the Microsoft Azure MarketplaceMarch 7, 2024 | edition.cnn.comBIMI International Medical IncApril 27, 2024 | Behind the Markets (Ad)Better than Bitcoin? The Biotech Stock with 46,751% Potential4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.March 6, 2024 | msn.comNavigating new spam policies: A guide to effective cold email outreachMarch 1, 2024 | finance.yahoo.comValimail Awarded 2023 TMCnet Zero Trust Security Excellence AwardFebruary 29, 2024 | finance.yahoo.comRed Sift Doubles Down on Mission to Help Safeguard Retail and Hospitality Organizations from Brand AbuseFebruary 24, 2024 | benzinga.comBIMI Intl Medical Stock (NASDAQ:BIMI), Short Interest ReportFebruary 22, 2024 | msn.comPowerDMARC to Showcase Domain Security Solutions at Global Cybersecurity Events in QatarFebruary 12, 2024 | finanznachrichten.deValimail Partners with Defending Digital Campaigns to Prevent Email Impersonation Ahead of 2024 Election SeasonFebruary 1, 2024 | forbes.com20 Cybersecurity Strategies Businesses Can Implement TodayJanuary 3, 2024 | finance.yahoo.comBIMI Announces Results of 2023 Annual General Meeting of StockholdersDecember 19, 2023 | msn.comBIMI International Medical reports Q3 resultsDecember 17, 2023 | morningstar.comBIMI International Medical Inc BIMINovember 28, 2023 | msn.comBIMI announces buyback of 7.07M warrantsNovember 28, 2023 | finance.yahoo.comBIMI Announces Buyback of WarrantsNovember 27, 2023 | msn.comBIMI receives Nasdaq notification of non-compliance with listing ruleNovember 27, 2023 | msn.comBIMI International Medical reports Q2 resultsNovember 8, 2023 | benzinga.comBIMI Announces Subsidiary Phenix Bio Inc.'s New Product LaunchNovember 8, 2023 | finance.yahoo.comBIMI Announces Subsidiary Phenix Bio Inc.’s New Product LaunchOctober 30, 2023 | finance.yahoo.comBIMI International Medical Inc. Announces Subsidiary Phenix Bio Inc’s Appointment of Mainland China Non-Exclusive DistributorOctober 30, 2023 | finance.yahoo.comBIMI International Medical Inc. Announces Subsidiary Phenix Bio Inc’s Appointment of Hong Kong, Taiwan, and Macau Exclusive DistributorSee More Headlines Receive BIMI Stock News and Ratings via Email Sign-up to receive the latest news and ratings for BIMI and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Today4/27/2024Next Earnings (Estimated)5/17/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Drugs, proprietaries, & sundries Sub-IndustryN/A Current SymbolNASDAQ:BIMI CUSIPN/A CIK1213660 Webwww.bimihc.com Phone(212) 542-0028Fax86-24-8563-1159Employees296Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-22,390,000.00 Net Margins-94.58% Pretax Margin-96.84% Return on Equity-133.29% Return on Assets-33.85% Debt Debt-to-Equity RatioN/A Current Ratio1.21 Quick Ratio0.86 Sales & Book Value Annual Sales$11.83 million Price / Sales1.21 Cash FlowN/A Price / Cash FlowN/A Book Value$1.36 per share Price / Book0.90Miscellaneous Outstanding Shares11,590,000Free Float3,591,000Market Cap$14.26 million OptionableNot Optionable Beta1.58 7 Stocks to Own Before the 2024 ElectionLooking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.Get This Free Report Key ExecutivesMr. Tiewei Song (Age 52)CEO & Director Comp: $825kMs. Baiqun Zhong (Age 60)Interim Chief Financial Officer Comp: $104.17kMr. Xiaoping Wang (Age 43)Chief Operating Officer Comp: $500kMr. Fnu Oudom (Age 69)Chairman of Board & President Key CompetitorsZK International GroupNASDAQ:ZKINCosmos HealthNASDAQ:COSMTRxADE HEALTHNASDAQ:MEDSKiora PharmaceuticalsNASDAQ:KPRXAytu BioPharmaNASDAQ:AYTUView All Competitors BIMI Stock Analysis - Frequently Asked Questions How have BIMI shares performed in 2024? BIMI's stock was trading at $2.19 at the start of the year. Since then, BIMI shares have decreased by 43.8% and is now trading at $1.23. View the best growth stocks for 2024 here. Are investors shorting BIMI? BIMI saw a drop in short interest in April. As of April 15th, there was short interest totaling 7,100 shares, a drop of 57.7% from the March 31st total of 16,800 shares. Based on an average trading volume of 49,700 shares, the short-interest ratio is currently 0.1 days. Currently, 0.8% of the company's shares are sold short. View BIMI's Short Interest. When is BIMI's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Friday, May 17th 2024. View our BIMI earnings forecast. When did BIMI's stock split? BIMI shares reverse split before market open on Monday, December 12th 2022. The 1-10 reverse split was announced on Monday, December 12th 2022. The number of shares owned by shareholders was adjusted after the closing bell on Monday, December 12th 2022. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split. What other stocks do shareholders of BIMI own? Based on aggregate information from My MarketBeat watchlists, some companies that other BIMI investors own include iBio (IBIO), Airgain (AIRG), AIM ImmunoTech (AIM), Aytu BioPharma (AYTU), Nuwellis (CHFS), Clovis Oncology (CLVS), Inovio Pharmaceuticals (INO), Lianluo Smart (LLIT). How do I buy shares of BIMI? Shares of BIMI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:BIMI) was last updated on 4/27/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyHe Is Giving Away BitcoinCrypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithThe World's First "$20 Trillion Drug?"Behind the MarketsEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest MetalsFed launches fourth dollar overhaulStansberry ResearchBiden out June 13; Kamala won’t replace him?Paradigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BIMI Holdings Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
